Amyloid precursor protein (APP)‐derived peptides exemplify the case where the ratio of Aβ 42 to Aβ 40 (Aβ 42/40 ratio) is superior to the concentration of Aβ 42 alone in discriminating patients with AD from controls (Shoji et al., 1998). This evidence concerns the gene APP and Alzheimer disease.